Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence (AI)-powered software platforms.

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

I contend this is the case, which makes the stock's recent setback a fantastic buying opportunity. Here's the deal.

The chemical-and-materials maker on Tuesday forecast sales around $12.85 billion and adjusted earnings per share around $4.40. The Wilmington, Del., company previously guided for sales between $12.8 ...

Molson Coors forecast a bigger drop in its annual profit on Tuesday, hit by tariff impacts on costs of aluminum it uses for its beverage cans amid macroeconomic uncertainty in the U.S.

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

Palantir reported better-than-expected quarterly results, but restaurant chain Denny's and Hims & Hers Health posted disappointing results.

These 10 stocks could mint the next wave of millionaires › SBA Communications (NASDAQ:SBAC), a leading owner and operator of wireless communications towers, announced results for the second quarter on ...

EMCOR Group delivered above-expectations results in Q2 2025 with the management raising its full-year guidance. Read more on ...